What smart money is saying about Progyny Inc.
1 fund in our archive has pitched Progyny Inc. — most recently Buffalo funds Mid Cap Growth Fund in June 2026.
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys. The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
Get an email when a fund buys, sells or pitches it
Position history
Between Q1 2025 and Q2 2026, 3 fund letters reported a position in Progyny Inc., with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 2 | 0 | 0 | 1 |
| Q1 2025 | 1 | 0 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 3 positions
- June 2026
Listed in Signia Capital Management Small Cap Value Strategy’s reported holdings.
Progyny Inc. - June 2026
“Progyny Inc. (PGNY) is a leading fertility and family-building benefits management provider for self-insured employers. The company demonstrates best-in-class fertility outcomes and is positioned to benefit from the societal trend towards later- in-life pregnancies in developed countries. They enjoy an asset-light, cash-generative business model along with strong net-cash balance sheet, undemanding valuation multiple, and are rapidly shrinking the share count through repurchases. The company reported earnings that beat investor expectations in the quarter and the stock outperformed but remained a compelling investment opportunity in our view.”
Progyny Inc. - HoldsSignia CapitalMarch 2025
Listed in Signia Capital’s reported holdings.
Progyny Inc.
Fund coverage · 1 thesis
- Buffalo funds Mid Cap Growth FundJune 2026
Progyny provides fertility benefits management for employers and is supported by best-in-class outcomes, an asset-light model, cash generation, and repurchases.
Read the full thesis
Read every full thesis on Progyny Inc.
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→